Patent ID: 8586082

Claim:
Solid pharmaceutical dosage form which can be administered orally and has rapid release, the pharmaceutical dosage form comprising an active ingredient (I) that is 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide and an excipient, wherein the pharmaceutical dosage form (a) comprises the active ingredient (I) in amorphous form or thermodynamically metastable crystal modification, and (b) 80% of active ingredient (I) is released in a period of less than 2 hours in USP release method with apparatus 2 (paddle); and further wherein the active ingredient (I) is obtained in amorphous form by dissolving in a solvent or further wherein the active ingredient (I) is obtained in amorphous form or converted into a thermodynamically metastable crystal modification by melting or further wherein the active ingredient (I) is obtained in amorphous form or converted into a thermodynamically metastable crystal modification by melt extrusion.